Home   Business   Life Science

Life Science




Mission Therapeutics confirms potential Alzheimer’s and Parkinson’s targets with AbbVie

Mission Therapeutics confirms potential Alzheimer’s and Parkinson’s targets with AbbVie

Mission Therapeutics confirms potential Alzheimer’s and Parkinson’s targets with AbbVie

Several enzymes have been identified under the collaboration.

3

Chinese Medical Systems to invest £25m by plugging into AstraZeneca and Cambridge Judge Business School life science networks

Chinese Medical Systems to invest £25m by plugging into AstraZeneca and Cambridge Judge Business School life science networks

Chinese Medical Systems to invest £25m by plugging into AstraZeneca and Cambridge Judge Business School life science networks

Chinese Medical Systems will offer seed investment capital in five-year programme.


Martin Frost: Why I’m standing down as CEO of CMR Surgical - and Per Vegard Nerseth is the right man to succeed me

Martin Frost: Why I’m standing down as CEO of CMR Surgical - and Per Vegard Nerseth is the right man to succeed me

Martin Frost: Why I’m standing down as CEO of CMR Surgical - and Per Vegard Nerseth is the right man to succeed me

He has led the robotics company from start-up to billion-dollar status and it is set to transform minimal access surgery.


Healx signs deal with Boehringer Ingelheim to aid fight against rare neurological diseases

Healx signs deal with Boehringer Ingelheim to aid fight against rare neurological diseases

Healx signs deal with Boehringer Ingelheim to aid fight against rare neurological diseases

The Cambridge company will use its Healnet AI platform to help identify new indications.


BiologIC’s factory-in-a-box means faster, cheaper cures

BiologIC’s factory-in-a-box means faster, cheaper cures

BiologIC’s factory-in-a-box means faster, cheaper cures

Coaching cells to revert to healthy activity is core of simplified process


Cycle Pharmaceuticals signs partnership with Catalent to develop its rare disease drugs

Cycle Pharmaceuticals signs partnership with Catalent to develop its rare disease drugs

Cycle Pharmaceuticals signs partnership with Catalent to develop its rare disease drugs

Zydis technology will be applied to four of the Cambridge company’s products.


OKRA Technologies becomes Veeva partner to drive AI into life science decision-making

OKRA Technologies becomes Veeva partner to drive AI into life science decision-making

OKRA Technologies becomes Veeva partner to drive AI into life science decision-making

The St John’s Innovation Park company will integrate its platform into Veeva CRM Suggestions


PredictImmune to launch study of PredictSURE IBD test in US with Crohn’s & Colitis Foundation

PredictImmune to launch study of PredictSURE IBD test in US with Crohn’s & Colitis Foundation

PredictImmune to launch study of PredictSURE IBD test in US with Crohn’s & Colitis Foundation

PRECIOUS study follows successful launch of IBD prognostic test in UK and Ireland.


Horizon Discovery sells animal models business to Envigo as it refocuses on high-growth areas

Horizon Discovery sells animal models business to Envigo as it refocuses on high-growth areas

Horizon Discovery sells animal models business to Envigo as it refocuses on high-growth areas

Staff and assets at its US-based research models business will transfer over.


LMB unveils vision for next generation of Nobel Prize-winning cryo-EM technology

LMB unveils vision for next generation of Nobel Prize-winning cryo-EM technology

LMB unveils vision for next generation of Nobel Prize-winning cryo-EM technology

Chris Russo's group has shown how the prohibitive costs of cryo-electron microscopy could be slashed.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More